Accounts Payable, Current in USD of Achilles Therapeutics plc from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Achilles Therapeutics plc quarterly Accounts Payable, Current history and change rate from Q4 2020 to Q2 2024.
  • Achilles Therapeutics plc Accounts Payable, Current for the quarter ending 30 Jun 2024 was $2.87M, a 58.4% decline year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Change (%)

Achilles Therapeutics plc Quarterly Accounts Payable, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.87M -$4.02M -58.4% 30 Jun 2024 6-K 14 Aug 2024
Q4 2023 $5.63M +$442K +8.52% 31 Dec 2023 6-K 14 Aug 2024
Q2 2023 $6.89M 30 Jun 2023 6-K 04 Aug 2023
Q4 2022 $5.19M +$1.47M +39.4% 31 Dec 2022 20-F 04 Apr 2024
Q4 2021 $3.72M -$2.59M -41.1% 31 Dec 2021 20-F 07 Mar 2023
Q4 2020 $6.31M 31 Dec 2020 20-F 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.